Spinifex Pharmaceuticals Pty Limited Announces Positive Phase 2 Results for EMA401 in Postherpetic Neuralgia
8/28/2012 10:05:18 AM
More...
|
Spinifex Pharmaceuticals Pty Limited Appoints Declan Doogan as Non-Executive Chairman
12/8/2011 10:00:07 AM
More...
|
Spinifex Pharmaceuticals Pty Limited Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Postherpetic Neuralgia
9/19/2011 11:24:24 AM
More...
|
Spinifex Pharmaceuticals Pty Limited Release: New Data on EMA401 in Model of Diabetic Neuropathy Presented at 21st Annual NEURODIAB Meeting
9/12/2011 10:26:25 AM
More...
|
Spinifex Pharmaceuticals Pty Limited Closes $19 Million Expanded Series B Round
8/23/2011 6:38:49 AM
More...
|
Spinifex Pharmaceuticals Pty Limited Secures A $12M Investment to Develop Pain Drug
9/3/2008 11:08:00 AM
More...
|
Spinifex Pharmaceuticals Pty Limited Secures AUD$3.25 Million investment To Develop Pain Therapy
10/19/2005 5:09:00 PM
More...
|